$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical News
Medical News
抗癌靶向药拉罗替尼
2025-10-19 11:44:20
Check Details
Vitrakvi说明书
2025-10-19 11:44:20
Check Details
FDA批准拉罗替尼上市
2025-10-19 11:44:20
Check Details
Laronib怎么服用
2025-10-19 11:44:20
Check Details
拉罗替尼——肺癌、乳腺癌病例展示
2025-10-19 11:44:20
Check Details
ASCO专家观点速递 :关于repotrectinib(洛普替尼)
2025-10-19 11:44:20
Check Details
Nintedanib的治疗效果
2025-10-19 11:44:20
Check Details
ALK阳性一线治疗药物--阿来替尼
2025-10-19 11:44:20
Check Details
阿来替尼适应症
2025-10-19 11:44:20
Check Details
阿来替尼的注意事项
2025-10-19 11:44:20
Check Details
阿来替尼获批上市
2025-10-19 11:44:20
Check Details
阿来替尼中文说明书
2025-10-19 11:44:20
Check Details
1
2
...
6791
6792
6793
6794
6795
6796
6797
...
7870
7871
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Analysis (Biktarvy) of the 48-hour efficacy of Bicentanide Tablets in blocking HIV infection
2
Caution is needed when using denosumab: which serious side effects should be closely monitored?
3
Best time to take Luqu Bopa (Wenkedake) and precautions
4
Instructions for Aishakangzuo Capsules
5
How much does a box of lenvatinib/lenvatinib capsules cost, and can it be reimbursed?
6
Which manufacturer produces Belumosudil tablets and what is the quality?
7
Tips on possible risks of using Brivaracetam
8
The application effect of Alpelisib in advanced breast cancer
9
What are the adverse reactions of fostatinib/fotantinib?
10
Is serputinib/serpatinib (Ruitu) a targeted anti-cancer drug?
11
Bezutivan combined with pembrolizumab and lenvatinib shows potential in advanced clear cell renal cell carcinoma
12
How to follow and implement the usage and dosage of Besudil/Elac